00911nas a2200253   4500000000100000000000100001008004100002260001500043653001800058653002500076100002600101700001200127700001700139700001100156700001400167700001700181700001800198245008700216856005500303300000800358490000600366520027100372022001400643       2026                            d  c2026-04-1710aPharmaceutics10aScientific community1 aEmmanuel Enoch Dzakah1 aChao Ni1 aXiaomin Feng1 aWei Hu1 aBing Zhao1 aShixing Tang1 aClifford Pang00aModernizing drug development and ensuring global equity in the organoid revolution  uhttps://www.nature.com/articles/s42003-026-10076-4  a5400 v93 aGlobal regulatory shifts are accelerating the move from animal models to human-relevant systems like organoids and MPS. Without deliberate inclusion, Africa risks exclusion despite its high disease burden, limiting global health equity and full scientific potential.  a2399-3642